Title : GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.

Pub. Date : 2018 Sep 4

PMID : 29570299






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 GE11-directed reversibly cross-linked polymersomal doxorubicin has emerged as an advanced alternative to Lipo-Dox for treatment of EGFR-overexpressing ovarian cancers. Doxorubicin epidermal growth factor receptor Homo sapiens
2 Here, GE11 peptide-modified reversibly cross-linked polymersomal doxorubicin (GE11-PS-Dox) was investigated as an advanced treatment for SKOV3 human ovarian tumors, which overexpress epidermal growth factor receptor (EGFR). Doxorubicin epidermal growth factor receptor Homo sapiens